Home blood pressure measurements: Advantages and disadvantages compared to office and ambulatory monitoring

References

• O’Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322: 531–6.
   PubMed Web of Science ®Google Scholar
• 1999 World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17: 151–83.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
   PubMed Web of Science ®Google Scholar
• McAlister FA, Straus SE. Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. BMJ. 2001;322:908–11.
   Google Scholar
• Williams JS, Brown SM, Conlin PR. Videos in clinical medicine. Blood-pressure measurement. N Engl J Med. 2009; 360:e6.
   PubMed Web of Science ®Google Scholar
• Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505–26.
   PubMed Web of Science ®Google Scholar
• Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. J Cardiovasc Nurs. 2008;23:299–323.
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Moan A, Petrin J, Weder AB, Zweifler AJ, Julius S. Evaluation of self-measured home vs. clinic intra-arterial blood pressure. Blood Press. 1993;2:28–34.
   PubMedGoogle Scholar
• Kjeldsen SE, Hedner T, Jamerson K, Julius S, Haley WE, Zabalgoitia M, et al. Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension. 1998;31:1014–20.
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Hedner T, Syvertsen JO, Lund-Johansen P, Hansson L. Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study. Blood Press. 2002;11:371–6.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508–15.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, O’Brien E, Pickering T, Staessen JA, Parati G, Myers M, Palatini P. When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens. 2003;16:87–91.
   PubMed Web of Science ®Google Scholar
• Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–53.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: International Database of Home blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014; 63:675–82.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45:203–8.
   PubMed Web of Science ®Google Scholar
• Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.
   PubMed Web of Science ®Google Scholar
• Boubouchairopoulou N, Karpettas N, Athanasakis K, Kollias A, Protogerou AD, Achimastos A, Stergiou GS. Cost estimation of hypertension management based on home blood pressure monitoring alone or combined office and ambulatory blood pressure measurements. J Am Soc Hypertens. 2014;8:732–8.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Siontis KC, Ioannidis JP. Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously. Hypertension. 2010;55:1301–3.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19:801–7.
   PubMed Web of Science ®Google Scholar
• Niiranen TJ, Hanninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010;55:1346–51.
   PubMed Web of Science ®Google Scholar
• Asayama K, Thijs L, Brguljan-Hitij J, Niiranen TJ, Hozawa A, Boggia J, et al. Risk stratification by self-measured home blood pressure across categories of conventional blood pressure: a participant-level meta-analysis. PLoS Med. 2014;11:e1001591.
   PubMed Web of Science ®Google Scholar
• Manning L, Hirakawa Y, Arima H, Wang X, Chalmers J, Wang J, et al. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol. 2014;13:364–73.
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.
   PubMed Web of Science ®Google Scholar
• Hara A, Tanaka K, Ohkubo T, Kondo T, Kikuya M, Metoki H, et al. Ambulatory versus home versus clinic blood pressure: the association with subclinical cerebrovascular diseases: the Ohasama study. Hypertension. 2012;59:22–8.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Ntineri A, Kollias A, Ohkubo T, Imai Y, Parati G. Blood pressure variability assessed by home measurements: a systematic review. Hypertens Res. 2014;37: 565–72.
   PubMed Web of Science ®Google Scholar
• Ushigome E, Fukui M, Hamaguchi M, Tanaka T, Atsuta H, Mogami SI, et al. Factors affecting variability in home blood pressure in patients with type 2 diabetes: post hoc analysis of a cross-sectional multicenter study. J Hum Hypertens. 2014;28:594–9.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Satoh M, Kikuya M, Ohkubo T, Hirano M, Inoue R, et al. Day-to-day variability in home blood pressure is associated with cognitive decline: the Ohasama study. Hypertension. 2014;63:1333–8.
   PubMed Web of Science ®Google Scholar
• Wei FF, Li Y, Zhang L, Xu TY, Ding FH, Wang JG, Staessen JA. Beat-to-beat, reading-to-reading, and day-to-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension. 2014;63:790–6.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhao Y, Lu F, Zhang H, Diao Y. Day-by-day variability in self-measured blood pressure at home: effects on carotid artery atherosclerosis, brachial flow-mediated dilation, and endothelin-1 in normotensive and mild—moderate hypertensive individuals. Blood Press Monit. 2013;18:316–25.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.
   PubMed Web of Science ®Google Scholar
• Fletcher BR, Hartmann-Boyce J, Hinton L, McManus RJ. The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. Am J Hypertens. 2015 February 26 [Epub ahead of print].
   Google Scholar
• Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D, et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol. 2014;63:834–5.
   PubMed Web of Science ®Google Scholar
• Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res. 2011;34:87–90.
   Google Scholar
• Strauch B, Petrak O, Zelinka T, Rosa J, Somloova Z, Indra T, et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J Hypertens. 2013;31:2455–61.
   PubMed Web of Science ®Google Scholar
• Bailey B, Carney SL, Gillies AA, Smith AJ. Antihypertensive drug treatment: a comparison of usual care with self blood pressure measurement. J Hum Hypertens. 1999;13: 147–50.
   PubMed Web of Science ®Google Scholar
• McKenney JM, Munroe WP, Wright JT Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol. 1992;32:277–83.
   PubMed Web of Science ®Google Scholar
• Rudd P, Miller NH, Kaufman J, Kraemer HC, Bandura A, Greenwald G, Debusk RF. Nurse management for hypertension. A systems approach. Am J Hypertens. 2004;17:921–7.
   PubMed Web of Science ®Google Scholar
• Vaur L, Dubroca II, Dutrey-Dupagne C, Genes N, Chatellier G, Bouvier-d’Yvoire M, et al. Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs. Blood Press Monit. 1998;3:107–14.
   PubMedGoogle Scholar
• Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, Carey K. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285–92.
   Google Scholar
• Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000;20:1384–9.
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004;329:145.
   PubMed Web of Science ®Google Scholar
• McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312:799–808.
   PubMed Web of Science ®Google Scholar
• Nomura K, Asayama K, Thijs L, Niiranen TJ, Lujambio I, Boggia J, et al. Thresholds for conventional and home blood pressure by sex and age in 5018 participants from 5 populations. Hypertension. 2014;64:695–701.
   PubMed Web of Science ®Google Scholar
• Kollias A, Dafni M, Poulidakis E, Ntineri A, Stergiou GS. Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis. J Hypertens. 2014;32:2315–31.
   PubMed Web of Science ®Google Scholar